Allurion Technologies announced clinical results from two new studies on the Elipse Gastric Balloon

Allurion Technologies announced clinical results from two new studies on the Elipse Gastric Balloon recently during ObesityWeek 2020 the company reports in a media release. The...

Glympse Bio clears first-in-human safety study of its injectable biosensors

Diagnosing nonalcoholic steatohepatitis (NASH)—the excessive buildup of fats in the liver that can lead to liver cancer, failure and the need for a transplant—has...

Latest articles